A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study, involving a 4-week treatment period, designed to test the ability of
investigational study drug ARRY-371797 to reduce pain in patients with moderate to severe
pain due to osteoarthritis (OA) of the knee, and to further evaluate the drug's safety.
Approximately 150 patients from the US will be enrolled in this study.